EC Number   |
Application |
Reference |
|---|
    3.2.1.20 | agriculture |
possilbe target in mite control |
707289 |
| 3.2.1.20 | biotechnology |
expression of the enzyme in rice plants can transduce enhanced resistance against sheath blight pathogen Rhizoctonia solani by inactivation of the RS toxin |
-, 655817 |
| 3.2.1.20 | diagnostics |
the neutral alpha-glucosidase might be a good epididymal marker |
682809 |
| 3.2.1.20 | medicine |
combination of biochemical and structural investigations will give a lot of information for developing enzyme enhancement therapy (EET) for Pompe disease |
691865 |
| 3.2.1.20 | medicine |
enzyme activity measured at the first month after microsurgical vasoepididymostomy is an early and independent predictor of patency and natural pregnancy |
749578 |
| 3.2.1.20 | medicine |
enzyme inhibition as therapeutic target for diabetes, in cancer, viral infections and in lysosomal storage diseases |
707664 |
| 3.2.1.20 | medicine |
glycogen storage disease is caused by lysosomal acid alpha-glucosidase deficiency. When injected intravenously, the recombinant enzyme from mouse milk corrects the acid alpha-glucosidase deficiency in heart and skeletal muscle of glycogen storage disease type II knockout mice |
393343 |
| 3.2.1.20 | medicine |
inhibitors from Spiraea cantoniensis could be physiologically useful for treatment of diabetes |
692721 |
| 3.2.1.20 | medicine |
inhibitors may serve as lead to develop drugs for treatment of type 2 diabetes |
694600 |
| 3.2.1.20 | medicine |
inhibitors of alpha-glucosidase are promising candidates for the development of antitype II diabetics and anti-AIDS drugs |
693568 |
